Who Are Adopters of Pharmacogenomics Among U.S. Physicians?
Who Are Adopters of Pharmacogenomics Among U.S. Physicians?E.J. Stanek, C.L. Sanders, J.R. Teagarden, K.A. Johansen, R.E. Aubert, B.C. Agatep, M. Khalid, A. Patel , F.W. Frueh, R.S. Epstein An estimated 13% of US physicians have adopted PGx testing, while 26% anticipate adoption. Surprisingly, almost all believe that a patient’s genetic makeup influences drug therapy. The contrast between acceptance of PGx as a therapeutic modifier and actual adoption rate highlights the need to clearly demonstrate patient benefit and the importance of physician education. Presented: 59th Annual Meeting of The American Society of Human Genetics, Honolulu, HI. |